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Sexual steroid hormones are known to influence the endothe-
lial function of blood vessels. Several studies have shown an asso-
ciation between increased levels of estradiol and varicose veins in
women. Also, the effect of pregnancy in the diameter of the veins
and the development of reflux and varicose veins has been demon-association between sexual steroid hormones and varicose veins in
males. The important finding in this report is that estradiol and
testosterone serum levels were higher in refluxing veins of the
lower extremities when compared to those from the arm veins of
the same patients. It is also interesting that the serum levels of
estradiol and testosterone were significantly higher in lower ex-
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Volume 51, Number 3 Labropoulos 647tremities than the upper extremities in the control group. No
difference was detected in the hemoglobin, platelets, and white
blood cell count in neither group nor the extremities. There were
20 patients and 20 controls. Of the 20 patients, only 2 were in class
2 and 2 had ulceration, while 9 had swelling and 7 had skin
discoloration. Obviously with this low number in each CEAP class,
and many other factors being present, it is difficult to make any
solid conclusions. For example, it would have been nice to have all
20 patients in class 2. In this way, the patients were likely to be
younger which would match the age of the control group. Despite
the limitations in the design of the study, the findings deserve great
attention as they point out that local hormone regulation may
be associated with the development of varicose veins. A largerwould have been ideal. The authors have clearly described the
limitations of the study and report their findings as a pilot data, which
is appropriate. They also concluded that further clinical and laboratory
work is needed. Sexual hormones are known to modify the synthesis
and/or the bioactivity of NO, PGI2, endothelium-derived hyperpo-
larizing factor (EDHF), and the endothelium-derived contracting
factors. These functions have an effect on the contractility and relax-
ation of the vascular smoothmuscle.Multiple reports have shown that
sexual hormone receptors are expressed both on the endothelium and
the vascular smoothmuscle. Gender differences on the contractility of
the vascular smoothmuscle have also beenwell documented in animal
models. However, the sexual hormone receptor subtypes, distribu-
tion, and theway bywhich they affect the function of the vascular cellssample representing all the CEAP classes in adequate numbers needs to be investigated further.
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